Cargando…

Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January−September 2021

We assessed the impact of COVID-19 vaccination in Italy, by estimating numbers of averted COVID-19 cases, hospitalisations, ICU admissions and deaths between January and September 2021, by age group and geographical macro areas. Timing and speed of vaccination programme implementation varied slightl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sacco, Chiara, Mateo-Urdiales, Alberto, Petrone, Daniele, Spuri, Matteo, Fabiani, Massimo, Vescio, Maria Fenicia, Bressi, Marco, Riccardo, Flavia, Del Manso, Martina, Bella, Antonino, Pezzotti, Patrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2021
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619872/ https://www.ncbi.nlm.nih.gov/pubmed/34823637 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.47.2101001

Ejemplares similares

Risk and protective factors for SARS-CoV-2 reinfections, surveillance data, Italy, August 2021 to March 2022
por: Sacco, Chiara, et al.
Publicado: (2022)

Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022
por: Fabiani, Massimo, et al.
Publicado: (2023)

Socioeconomic patterns and COVID-19 outcomes before, during and after the lockdown in Italy (2020)
por: Mateo-Urdiales, Alberto, et al.
Publicado: (2021)

Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023
por: Fabiani, Massimo, et al.
Publicado: (2023)

Impact of tiered restrictions on human activities and the epidemiology of the second wave of COVID-19 in Italy
por: Manica, Mattia, et al.
Publicado: (2021)

Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy– Update on the 28th of March 2021
por: Mateo-Urdiales, Alberto, et al.
Publicado: (2021)

Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021
por: Mateo-Urdiales, Alberto, et al.
Publicado: (2021)

Excess Mortality in Italy During the COVID-19 Pandemic: Assessing the Differences Between the First and the Second Wave, Year 2020
por: Dorrucci, Maria, et al.
Publicado: (2021)

Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19
por: Mateo-Urdiales, Alberto, et al.
Publicado: (2023)

Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
por: Fabiani, Massimo, et al.
Publicado: (2021)

Estimating SARS‐CoV‐2 infections and associated changes in COVID‐19 severity and fatality
por: Marziano, Valentina, et al.
Publicado: (2023)

Differences in the incidence and clinical outcomes of SARS-CoV-2 infection between Italian and non-Italian nationals using routine data
por: Fabiani, M., et al.
Publicado: (2022)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022
por: Sacco, Chiara, et al.
Publicado: (2022)

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)
por: Petrone, Daniele, et al.
Publicado: (2023)

Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study
por: Fabiani, Massimo, et al.
Publicado: (2023)

Spatiotemporal distribution and determinants of measles incidence during a large outbreak, Italy, September 2016 to July 2018
por: Andrianou, Xanthi D, et al.
Publicado: (2019)

Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022
por: van Iersel, Senna C.J.L., et al.
Publicado: (2023)

Geographic heterogeneity of the epidemiological impact of the COVID-19 pandemic in Italy using a socioeconomic proxy-based classification of the national territory
por: Petrelli, Alessio, et al.
Publicado: (2023)

Detection of a chikungunya outbreak in Central Italy, August to September 2017
por: Venturi, Giulietta, et al.
Publicado: (2017)

Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2022)

Spatial variability in the reproduction number of Ebola virus disease, Democratic Republic of the Congo, January–September 2019
por: Mizumoto, Kenji, et al.
Publicado: (2019)

Secondary transmission of COVID-19 in preschool and school settings in northern Italy after their reopening in September 2020: a population-based study
por: Larosa, Elisabetta, et al.
Publicado: (2020)

Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021
por: Meslé, Margaux MI, et al.
Publicado: (2021)

Epidemiological characteristics of COVID-19 cases in non-Italian nationals notified to the Italian surveillance system
por: Fabiani, Massimo, et al.
Publicado: (2021)

Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021
por: Benschop, Kimberley SM, et al.
Publicado: (2021)

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
por: Ireland, Georgina, et al.
Publicado: (2022)

Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020
por: Okada, Pilailuk, et al.
Publicado: (2020)

Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy
por: Guzzetta, Giorgio, et al.
Publicado: (2021)

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020
por: Singanayagam, Anika, et al.
Publicado: (2020)

First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
por: Spiteri, Gianfranco, et al.
Publicado: (2020)

Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021
por: Mazagatos, Clara, et al.
Publicado: (2021)

Unexposed populations and potential COVID-19 hospitalisations and deaths in European countries as per data up to 21 November 2021
por: Chapman, Lloyd A C, et al.
Publicado: (2022)

Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020
por: McDonald, Helen I, et al.
Publicado: (2020)

Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021
por: Tran Kiem, Cécile, et al.
Publicado: (2021)

Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020
por: Sullivan, Sheena G, et al.
Publicado: (2020)

A comparison of COVID-19 incidence rates across six European countries in 2021
por: Padget, Michael, et al.
Publicado: (2023)

Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020
por: Nicolay, Nathalie, et al.
Publicado: (2020)

Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021
por: Marrone, Gaetano, et al.
Publicado: (2022)

Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
por: Suarez Castillo, Milena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p3l7dfu8jh8hoif6d497thg3fb